Core Viewpoint - The company, Huagong Technology, has announced its plan to issue H-shares and list them on the Hong Kong Stock Exchange to enhance its international business development and strategic goals [3][24]. Group 1: Board Meeting Details - The board meeting was held on January 27, 2026, via telecommunication, with all 9 directors present and voting [2]. - The meeting was chaired by Chairman Ma Xinqiang, and the resolutions passed were in compliance with the Company Law and the Articles of Association [2]. Group 2: H-Share Issuance and Listing Proposal - The board approved the proposal for issuing H-shares and listing them on the Hong Kong Stock Exchange, with unanimous support from all directors [3][6]. - The issuance will comply with relevant laws and regulations, including those from the China Securities Regulatory Commission and the Hong Kong Stock Exchange [3][10]. Group 3: Issuance Details - The H-shares will have a nominal value of RMB 1.00 per share and will be offered to both local and international investors [9][11]. - The issuance is planned to be completed within the validity period of the shareholders' resolution, with the timing dependent on market conditions [10][12]. - The total number of shares to be issued will not exceed 10% of the company's total share capital post-issuance, with a potential 15% over-allotment option for underwriters [12][19]. Group 4: Fund Utilization - Proceeds from the H-share issuance will be used for capacity expansion, R&D investment, and general corporate purposes, subject to shareholder approval [27][50]. Group 5: Governance and Compliance - The company will transition to a publicly listed company in both Shenzhen and Hong Kong after the H-share issuance [24]. - The board proposed to appoint an independent director residing in Hong Kong to enhance corporate governance [43][46]. Group 6: Regulatory and Administrative Actions - The company will apply for registration as a non-Hong Kong company in accordance with Hong Kong regulations [66]. - The board authorized the chairman to handle all matters related to the H-share issuance and listing, including communication with regulatory bodies [32][66].

Group 1 - The company held its 8th meeting of the 2nd Board of Directors on December 8, 2025, to discuss the issuance of H-shares and listing on the Hong Kong Stock Exchange [2][3][31] - The board unanimously approved the proposal to issue H-shares and apply for listing on the Hong Kong Stock Exchange [4][8][31] Group 2 - The H-shares will be ordinary shares with a nominal value of RMB 1.00, issued in foreign currency [7] - The listing will take place on the main board of the Hong Kong Stock Exchange, with the timing to be determined based on market conditions and regulatory approvals [10][12] - The issuance will include both a public offering in Hong Kong and an international placement [12][20] Group 3 - The maximum number of H-shares to be issued will not exceed 25% of the total share capital post-issuance, with an option for an additional 15% for over-allotment [14] - The pricing of the shares will be determined based on market conditions and investor demand [16] - The target investors include qualified international institutional investors and eligible domestic investors [18] Group 4 - The funds raised from the H-share issuance will be used for clinical development of core research pipelines, preclinical exploration, and general corporate purposes [33][34] - The board proposed to authorize the board and its authorized persons to handle all matters related to the issuance and listing of H-shares [35][50] Group 5 - The company will apply to register as a non-Hong Kong company in accordance with Hong Kong laws for the purpose of the H-share listing [52] - The board approved a profit distribution plan for retained earnings prior to the H-share issuance, ensuring that both existing and future shareholders share in the profits [54] Group 6 - The board agreed to draft a new set of articles of association applicable after the H-share issuance, in compliance with relevant laws and regulations [58][60] - The internal governance rules will be revised to align with the requirements of the H-share listing [63][65]

Group 1 - The core opinion of the legal opinion letter is that the procedures for convening and holding the shareholders' meeting of Xinghuan Information Technology (Shanghai) Co., Ltd. comply with relevant Chinese laws and regulations [2][3][4] - The meeting is scheduled for August 4, 2025, and the notice regarding the meeting has been disclosed through designated media, detailing voting methods, meeting time, location, and other relevant information [3][4] - The legal opinion confirms that the qualifications of the convenor and attendees of the shareholders' meeting are valid and comply with Chinese laws and the company's articles of association [5][6] Group 2 - The voting procedures for the shareholders' meeting were conducted in accordance with the company's rules and relevant laws, with both onsite and online voting options available [4][5] - The results of the voting indicate that several key proposals, including the issuance of H shares and related governance amendments, received over two-thirds approval from the shareholders present [8][10] - The legal opinion concludes that the voting results and procedures are legitimate and effective, affirming the legality of the meeting's outcomes [10][11]

Core Viewpoint - Shanghai Weir Semiconductor Co., Ltd. is proposing to issue H shares and list them on the Hong Kong Stock Exchange to enhance its international strategy and overseas business development, thereby increasing its financing capabilities and overall competitiveness [3][4][5]. Group 1: Meeting Details - The second extraordinary general meeting of shareholders is scheduled for June 18, 2025, at 14:00 in Shanghai [1][2]. - Shareholders must register and sign in to participate in the meeting, with provisions for both on-site and online voting [1][2]. Group 2: H Share Issuance Proposal - The company plans to issue H shares and list them on the main board of the Hong Kong Stock Exchange, with the issuance subject to regulatory approvals [3][4]. - The proposed issuance will consist of ordinary shares with a nominal value of RMB 1.00 each, and the issuance scale is capped at 5% of the total share capital post-issuance, with an option for an additional 15% through an over-allotment option [4][5]. - The issuance will target both public investors in Hong Kong and qualified international institutional investors [4][5]. Group 3: Use of Proceeds - The funds raised from the H share issuance will be allocated to key technology development, global market expansion, strategic investments, and general corporate purposes [7][8]. - The board is authorized to adjust the use of proceeds based on regulatory feedback and operational needs [8]. Group 4: Governance and Compliance - The company seeks authorization from shareholders for the board to handle all matters related to the H share issuance, including regulatory compliance and communication with relevant authorities [10][11]. - The decision regarding the issuance's validity will last for 18 months, extendable if regulatory approvals are obtained within that period [15][19]. Group 5: Amendments to Corporate Governance - The company plans to amend its articles of association and related governance rules to align with the requirements for H share issuance and listing [19][20]. - The proposed amendments will ensure compliance with both domestic and Hong Kong regulations [19][20].

Core Viewpoint - The company, Guangdong Chao Hong Ji Industrial Co., Ltd., has approved the draft of the Articles of Association applicable after the issuance and listing of H shares, which will be effective upon the completion of the listing process in Hong Kong [1][2]. Group 1: Company Structure and Governance - The company plans to issue H shares and list on the main board of the Hong Kong Stock Exchange, necessitating amendments to its Articles of Association and related rules [1][2]. - The draft Articles of Association and its attachments, including the rules for shareholder and board meetings, will take effect after approval at the first extraordinary general meeting in 2025 [2][3]. - The current Articles of Association will remain valid until the new ones come into effect, at which point they will automatically become invalid [2]. Group 2: Amendments to Articles of Association - The amendments include changing the reference from "Securities Exchange" to "Shenzhen Securities Exchange" and updating legal references to align with the new listing requirements [2][3]. - The company’s registered capital and share structure will be defined, with H shares being issued at a par value of RMB 1 per share [7][10]. - The company will ensure that all H shares are transferable in accordance with the laws and regulations of the listing jurisdiction [10][12]. Group 3: Shareholder Rights and Obligations - Shareholders will have rights to attend meetings and vote based on their shareholdings, with each share granting one vote [26]. - There are specific provisions regarding the transfer of shares, including restrictions on the transfer of shares within one year of issuance [30]. - The company will maintain a shareholder register, which serves as proof of share ownership, and will comply with relevant laws for lost shares [13][12]. Group 4: Board and Management Responsibilities - The board of directors is responsible for convening shareholder meetings within specified timeframes and must respond to requests for extraordinary meetings [52][54]. - Directors must adhere to legal obligations and avoid conflicts of interest, ensuring that their actions align with the company's best interests [101][102]. - The company will disclose information as required by law and cooperate with regulatory authorities in case of legal judgments affecting the company [36].